Kilroy gets a welcome boost at West8

Rezolute (RZLT) completed enrollment in its Phase 3 upLIFT study of ersodetug for tumor hyperinsulinism, with topline results expected in mid-2026. The study aims to reduce intravenous glucose use in 16 patients. Earlier interim results showed 7 of 8 participants met the primary endpoint. RZLT stock closed at $4.23, up 3.07% in afterhours.

PG&E estimates a $20B cost for San Francisco to acquire its grid, far higher than the city's $3.4B estimate. The utility's CEO said the takeover is not in the city's best interest, citing asset values and severance costs. The city must respond by Oct. 20, with PG&E arguing the city's offer is below market value.

UPS has invested $80 million in a new logistics hub in Clark, Pampanga, its largest investment in the Philippines. The 30,000-square-meter facility increases daily package handling capacity from 5,000 to 46,000 and reduces transit times. The hub aims to enhance services across 1,100 global trade lanes and support local businesses, according to UPS.

Japan and the US agreed on a $21B investment in a new chip plant by GlobalFoundries (GF) in New York, part of a $550B semiconductor initiative. GF's P/S ratio is high at 19.4x, and it is unprofitable. Insiders have bought $1.32M in shares recently. The GF Score is 42/100, indicating moderate performance.

Keller Group (LON:KLR) aims for £800M free cash flow, citing sustainable margins and a strong order book. The company expects 5% annual construction output growth in served markets. It reported £2.4B in orders, with North America at record levels. Keller plans to allocate 40% of free cash flow to dividends and acquisitions.

Lockheed Martin (LMT) CEO James Taiclet stated that defense demand is 'permanent' and announced plans to increase PAC-3 MSE interceptor production. Analyst Robert Stallard upgraded LMT to 'Buy' with a $600 price target, citing expected missile business growth. LMT stock has risen nearly 8% year-to-date.